A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties

This report describes the design, generation and testing of Ylanthia, a fully synthetic human Fab antibody library with 1.3E+11 clones. Ylanthia comprises 36 fixed immunoglobulin (Ig) variable heavy (VH)/variable light (VL) chain pairs, which cover a broad range of canonical complementarity-determining region (CDR) structures. The variable Ig heavy and Ig light (VH/VL) chain pairs were selected for biophysical characteristics favorable to manufacturing and development. The selection process included multiple parameters, e.g., assessment of protein expression yield, thermal stability and aggregation propensity in fragment antigen binding (Fab) and IgG1 formats, and relative Fab display rate on phage. The framework regions are fixed and the diversified CDRs were designed based on a systematic analysis of a large set of rearranged human antibody sequences. Care was taken to minimize the occurrence of potential posttranslational modification sites within the CDRs. Phage selection was performed against various antigens and unique antibodies with excellent biophysical properties were isolated. Our results confirm that quality can be built into an antibody library by prudent selection of unmodified, fully human VH/VL pairs as scaffolds.

[1]  Eric T. Boder,et al.  Yeast surface display for screening combinatorial polypeptide libraries , 1997, Nature Biotechnology.

[2]  H R Hoogenboom,et al.  By-passing immunization. Human antibodies from V-gene libraries displayed on phage. , 1991, Journal of molecular biology.

[3]  G. Winter,et al.  Phage antibodies: filamentous phage displaying antibody variable domains , 1990, Nature.

[4]  H. Kaplan,et al.  Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Michel C Nussenzweig,et al.  Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. , 2008, Journal of immunological methods.

[6]  Maxwell D Cummings,et al.  Universal Screening Methods and Applications of ThermoFluor® , 2006, Journal of biomolecular screening.

[7]  Andreas Plückthun,et al.  Biophysical properties of human antibody variable domains. , 2003, Journal of molecular biology.

[8]  D. Raab,et al.  The GeneOptimizer Algorithm: using a sliding window approach to cope with the vast sequence space in multiparameter DNA sequence optimization , 2010, Systems and Synthetic Biology.

[9]  Gary Walsh,et al.  Post-translational modifications in the context of therapeutic proteins , 2006, Nature Biotechnology.

[10]  R. Brezinschek,et al.  Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells. , 1997, The Journal of clinical investigation.

[11]  Duncan Low,et al.  Future of antibody purification. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  A. Plückthun,et al.  Transfer of engineered biophysical properties between different antibody formats and expression systems. , 2012, Protein engineering, design & selection : PEDS.

[13]  N. Lonberg,et al.  Human Monoclonal Antibodies from Transgenic Mice , 2008, Handbook of experimental pharmacology.

[14]  C. Hardman,et al.  Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens. , 2008, Protein engineering, design & selection : PEDS.

[15]  A. Plückthun,et al.  Yet another numbering scheme for immunoglobulin variable domains: an automatic modeling and analysis tool. , 2001, Journal of molecular biology.

[16]  Ulrich Siebenlist,et al.  Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genes , 1981, Cell.

[17]  E. H. Cohen,et al.  Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity , 2005, Nature Biotechnology.

[18]  Rivka Adar,et al.  Human Combinatorial Fab Library Yielding Specific and Functional Antibodies against the Human Fibroblast Growth Factor Receptor 3* , 2003, Journal of Biological Chemistry.

[19]  R M Hoet,et al.  Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. , 1999, Journal of molecular biology.

[20]  A. Plückthun,et al.  Trinucleotide phosphoramidites: ideal reagents for the synthesis of mixed oligonucleotides for random mutagenesis. , 1994, Nucleic acids research.

[21]  A. Plückthun,et al.  In vitro selection and evolution of functional proteins by using ribosome display. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  V. Pascual,et al.  Persistent expression of autoantibodies in SLE patients in remission , 2006, The Journal of experimental medicine.

[23]  D. Ejima,et al.  Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies , 2006, Proteins.

[24]  M. Lefranc,et al.  Sequence and evolution of the human germline V lambda repertoire. , 1996, Journal of molecular biology.

[25]  A M Lesk,et al.  Structural repertoire of the human VH segments. , 1992, Journal of molecular biology.

[26]  S. Urlinger,et al.  HuCAL PLATINUM, a synthetic Fab library optimized for sequence diversity and superior performance in mammalian expression systems. , 2011, Journal of molecular biology.

[27]  Haruki Nakamura,et al.  Systematic classification of CDR‐L3 in antibodies: Implications of the light chain subtypes and the VL–VH interface , 2009, Proteins.

[28]  Tristan J. Vaughan,et al.  Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library , 1996, Nature Biotechnology.

[29]  J. Maizel,et al.  Evolution of human immunoglobulin kappa J region genes. , 1982, The Journal of biological chemistry.

[30]  J. Thèze,et al.  Analysis of human VH gene repertoire expression in peripheral CD19+ B cells , 2004, Immunogenetics.

[31]  Narayan Jayaram,et al.  Germline VH/VL pairing in antibodies. , 2012, Protein engineering, design & selection : PEDS.

[32]  E. Söderlind,et al.  Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries , 2000, Nature Biotechnology.

[33]  H. Hoogenboom,et al.  Selecting and screening recombinant antibody libraries , 2005, Nature Biotechnology.

[34]  K. Stubenrauch,et al.  Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates. , 2009, Journal of pharmaceutical and biomedical analysis.

[35]  F. Gueneau,et al.  Transferring the Characteristics of Naturally Occurring and Biased Antibody Repertoires to Human Antibody Libraries by Trapping CDRH3 Sequences , 2012, PloS one.

[36]  M. Nussenzweig,et al.  A checkpoint for autoreactivity in human IgM+ memory B cell development , 2006, The Journal of experimental medicine.

[37]  V. Pascual,et al.  Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors , 2008, Proceedings of the National Academy of Sciences.

[38]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[39]  B. Murphy,et al.  An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus , 2004, Nature Medicine.

[40]  H. Yee,et al.  Establishment of a human somatic hybrid cell line for recombinant protein production. , 2002, Journal of biomedical science.

[41]  L. Presta,et al.  Humanization of an anti-p185HER2 antibody for human cancer therapy. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Carter.  Potent antibody therapeutics by design , 2006, Nature Reviews Immunology.

[43]  Kunihiro Hattori,et al.  Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization , 2010, Nature Biotechnology.

[44]  T. Tiller.  Single B cell antibody technologies , 2011, New Biotechnology.

[45]  T. Singer,et al.  Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration , 2012, mAbs.

[46]  Jan Berka,et al.  Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire , 2009, Proceedings of the National Academy of Sciences.

[47]  D R Burton,et al.  Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. , 1989, Science.

[48]  Thomas Waldmann,et al.  A novel solid phase technology for high-throughput gene synthesis. , 2008, BioTechniques.

[49]  P. Hudson,et al.  Recombinant antibody fragments. , 1998, Current opinion in biotechnology.

[50]  A. Honegger,et al.  The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies. , 2008, Journal of molecular biology.

[51]  B. Brocks,et al.  In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification. , 2008, Molecular immunology.

[52]  R. Brezinschek,et al.  Pairing of variable heavy and variable kappa chains in individual naive and memory B cells. , 1998, Journal of immunology.

[53]  M. Nussenzweig,et al.  Autoreactivity in human IgG+ memory B cells. , 2007, Immunity.

[54]  P. S. Andersen,et al.  Isolation of human antibody repertoires with preservation of the natural heavy and light chain pairing. , 2006, Journal of molecular biology.

[55]  Manqiu Cao,et al.  High-throughput generation and engineering of recombinant human antibodies. , 2001, Journal of immunological methods.

[56]  M. Taussig,et al.  Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites. , 1997, Nucleic acids research.

[57]  A. Jungbauer,et al.  Thermodynamic stability and formation of aggregates of human immunoglobulin G characterised by differential scanning calorimetry and dynamic light scattering. , 2006, Journal of biochemical and biophysical methods.

[58]  Nigel Jenkins,et al.  Post-translational Modifications of Recombinant Proteins: Significance for Biopharmaceuticals , 2008, Molecular biotechnology.

[59]  M. Nussenzweig,et al.  Predominant Autoantibody Production by Early Human B Cell Precursors , 2003, Science.

[60]  Dirk Ponsel,et al.  High Affinity, Developability and Functional Size: The Holy Grail of Combinatorial Antibody Library Generation , 2011, Molecules.

[61]  T. Tiller,et al.  B‐Cell Tolerance Checkpoints in Healthy Humans and Patients with Systemic Lupus Erythematosus , 2005, Annals of the New York Academy of Sciences.

[62]  C. Chapman,et al.  Rapid cytotoxicity of human B lymphocytes induced by VH4‐34 (VH4.21) gene‐encoded monoclonal antibodies, II , 1997, Clinical and experimental immunology.

[63]  George T Detitta,et al.  Thermofluor-based high-throughput stability optimization of proteins for structural studies. , 2006, Analytical biochemistry.

[64]  Jinquan Luo,et al.  Coevolution of antibody stability and Vκ CDR-L3 canonical structure. , 2010, Journal of molecular biology.

[65]  G. P. Smith,et al.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.

[66]  J. Engler,et al.  Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. , 2003, Journal of molecular biology.

[67]  G. Winter,et al.  Making antibodies by phage display technology. , 1994, Annual review of immunology.

[68]  A. Lesk,et al.  The structural repertoire of the human V kappa domain. , 1995, The EMBO journal.

[69]  S Minoshima,et al.  One-megabase sequence analysis of the human immunoglobulin lambda gene locus. , 1997, Genome research.

[70]  Linda O Narhi,et al.  High throughput thermostability screening of monoclonal antibody formulations. , 2010, Journal of pharmaceutical sciences.

[71]  L. Farinelli,et al.  By-passing in vitro screening—next generation sequencing technologies applied to antibody display and in silico candidate selection , 2010, Nucleic acids research.

[72]  Ida Retter,et al.  VBASE2, an integrative V gene database , 2004, Nucleic Acids Res..

[73]  A. Plückthun,et al.  Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. , 2000, Journal of molecular biology.

[74]  R. Brezinschek,et al.  Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. , 1997, The Journal of clinical investigation.

[75]  L. Boursier,et al.  Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions. , 2000, Molecular immunology.